日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer

一项关于药理学抗坏血酸、吉西他滨和白蛋白紫杉醇治疗转移性胰腺癌的随机试验

Bodeker, Kellie L; Smith, Brian J; Berg, Daniel J; Chandrasekharan, Chandrikha; Sharif, Saima; Fei, Naomi; Vollstedt, Sandy; Brown, Heather; Chandler, Meghan; Lorack, Amanda; McMichael, Stacy; Wulfekuhle, Jared; Wagner, Brett A; Buettner, Garry R; Allen, Bryan G; Caster, Joseph M; Dion, Barbara; Kamgar, Mandana; Buatti, John M; Cullen, Joseph J

Magnetic Resonance Imaging of Iron Metabolism with T2* Mapping Predicts an Enhanced Clinical Response to Pharmacologic Ascorbate in Patients with GBM

使用 T2* 映射对铁代谢进行磁共振成像可预测 GBM 患者对药物抗坏血酸的临床反应增强

Michael S Petronek, Varun Monga, Kellie L Bodeker, Michael Kwofie, Chu-Yu Lee, Kranti A Mapuskar, Jeffrey M Stolwijk, Amira Zaher, Brett A Wagner, Mark C Smith, Sandy Vollstedt, Heather Brown, Meghan L Chandler, Amanda C Lorack, Jared S Wulfekuhle, Jann N Sarkaria, Ryan T Flynn, Jeremy D W Greenlee,